Please enter a valid month/year e.g. 01/2015

Pick a date between March 2000 and November 2018

Showing 1 to 10 of 400
Title Reference number Published Last updated
Gemtuzumab ozogamicin for untreated acute myeloid leukaemia Reference number:TA545 TA00545 Published:November 2018 20181101 Last updated:November 2018 20181114
Eltrombopag for treating chronic immune (idiopathic) thrombocytopenic purpura Reference number:TA293 TA00293 Published:July 2013 20130701 Last updated:October 2018 20181026
Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura Reference number:TA221 TA00221 Published:April 2011 20110401 Last updated:October 2018 20181026
Dabrafenib with trametinib for adjuvant treatment of resected BRAF V600 mutation-positive melanoma Reference number:TA544 TA00544 Published:October 2018 20181001 Last updated:October 2018 20181017
Cabozantinib for untreated advanced renal cell carcinoma Reference number:TA542 TA00542 Published:October 2018 20181001 Last updated:October 2018 20181003
Tofacitinib for treating active psoriatic arthritis after inadequate response to DMARDs Reference number:TA543 TA00543 Published:October 2018 20181001 Last updated:October 2018 20181003
Inotuzumab ozogamicin for treating relapsed or refractory B-cell acute lymphoblastic leukaemia Reference number:TA541 TA00541 Published:September 2018 20180901 Last updated:September 2018 20180919
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma Reference number:TA540 TA00540 Published:September 2018 20180901 Last updated:September 2018 20180903
Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours Reference number:TA539 TA00539 Published:August 2018 20180801 Last updated:August 2018 20180829
Dinutuximab beta for treating neuroblastoma Reference number:TA538 TA00538 Published:August 2018 20180801 Last updated:August 2018 20180822